New biosimilar for arthritis tracked in Real-World study
NCT ID NCT06247722
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 40 times
Summary
This study follows 600 adults with moderate to severe rheumatoid arthritis who are already prescribed a biosimilar called Tyenne (similar to tocilizumab). Researchers want to see how many patients continue the treatment for 6 and 12 months. The study does not give any new medicine—it simply observes what happens in normal doctor visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Facharztpraxis für Innere Medizin
Naumburg, 06618, Germany
-
Facharztpraxis für Innere Medizin Ludwigsfelde
Ludwigsfelde, 14974, Germany
-
Klinische Forschung
Planegg, 82152, Germany
-
Rheumahaus Potsdam
Potsdam, 14467, Germany
-
Rheumapraxis Dr. Liebhaber Halle
Halle, 06128, Germany
-
Rheumatologische Facharztpraxis
Magdeburg, 39104, Germany
-
Rheumatologische Facharztpraxis Templin
Templin, 17268, Germany
-
Rheumatologische Schwerpunktpraxis Berlin
Berlin, 12161, Germany
Conditions
Explore the condition pages connected to this study.